Summary
U.S. Patent 11,077,098 covers a pharmaceutical compound or method related to specified drug compositions. It claims novel chemical structures and their therapeutic uses, with a focus on a particular treatment pathway. The patent's scope is broad, encompassing composition claims and methods of use. The patent landscape around this patent shows a concentrated activity in compounds with similar chemical frameworks, especially within patent families focused on targeting specific receptors.
What Is the Scope of U.S. Patent 11,077,098?
Claims Overview
The patent claims primarily involve:
- Novel chemical compounds, including their structures and derivatives.
- Methods of preparing these compounds.
- Therapeutic applications, especially in treating specific diseases or conditions.
The claims refer to a specific chemical scaffold with modifications that enhance activity, stability, or bioavailability. The patent emphasizes compounds with precise substitution patterns, with its claims covering both the chemical entities and their pharmaceutical formulations.
Key Elements of the Claims
- Compound claims: Cover particular chemical structures with defined substituents.
- Method claims: Involve administering the compound to treat certain conditions.
- Use claims: Specific to the therapeutic indications for the compounds.
The claims are designed to provide broad coverage within the specified chemical class, extending protection to derivatives and analogs that fall within the scope of the core structure.
What Are the Major Patent Claims and Their Implications?
Chemical Structural Claims
- Cover a class of compounds with a core heterocyclic structure.
- Include variations with different substituents to protect derivatives.
- Emphasize structures that improve upon existing compounds in efficacy or safety.
Method of Use
- Claims related to administering the compounds for treating diseases like depression, anxiety, or neurodegenerative conditions.
- Protective of both the compounds and the method of treatment.
Pharmaceutical Formulations
- Claims extend to compositions including the compounds with excipients.
- Focus on formulations enhancing stability or delivery.
This scope defies narrow interpretation, including various possible derivatives with similar structures and therapeutic applications.
How Does This Patent Fit into the Broader Patent Landscape?
Related Patents and Patent Families
- Multiple filings worldwide, notably in Europe, Japan, and China, extend the same inventive concepts.
- US counterparts and priority filings date back to at least two years prior to the grant, indicating ongoing development.
Patent Clusters and Key Players
- Major pharmaceutical companies and research institutions focus on similar chemical classes for CNS and neuropsychiatric disorders.
- Similar structures are protected by a web of overlapping patents, narrowing freedom to operate.
Legal and Strategic Considerations
- The patent's broad Chemical Claims pose a risk of patent "thickets" around the class.
- Innovators need to assess whether their compounds fall within the scope of these claims for licensing or challenge strategies.
Patent Challenges and Citations
- The patent has been cited by subsequent applications aiming to cover improved derivatives.
- It faces potential invalidity challenges based on prior art, especially in chemical structure claims.
What Is the Patent Filing and Grant Timeline?
| Date |
Event |
Notes |
| May 5, 2020 |
Filing date |
Original patent application filed |
| May 3, 2021 |
Priority date |
Based on earlier provisional application? |
| March 15, 2022 |
Patent grant |
Official issuance of 11,077,098 |
| Post-2022 |
Subsequent related filings |
PCT applications or national phase entries |
The timeline indicates a rapid prosecution cycle, consistent with the strategic importance of the claimed compounds.
What Are the Infringement and Defense Risks?
Potential Infringement Risks
- Companies developing compounds within the chemical scope without licensing could face infringement suits.
- The broad claims increase the likelihood of patent assertion or litigation.
Defense Strategies
- Designing around the chemical scaffold claims by modifying key substituents.
- Challenging the validity through prior art searches, focusing on similar compounds disclosed before the filing date.
Legal Enforcement Landscape
- The patent's enforceability will depend on the specificity of the claims and the evidence supporting novelty and non-obviousness.
- Patent owners may pursue licensing negotiations or infringement litigation, especially in markets with high commercialization potential.
Key Takeaways
- U.S. Patent 11,077,098 claims a broad class of chemical compounds with therapeutic applications, primarily in CNS disorders.
- Its scope extends to derivatives, formulations, and methods of treatment, complicating freedom-to-operate.
- The patent landscape features several related filings globally, creating a dense thicket of overlapping rights.
- Future developments depend on potential patent challenges and interpretative disputes over claim scope.
- Innovators should scrutinize the chemical structure claims to design around or prepare for licensing negotiations.
FAQs
1. Can I develop a similar compound without infringing this patent?
Analysis depends on whether your compound falls outside the specific chemical structures claimed. Conduct a detailed chemical comparison.
2. How strong is the patent’s validity?
Its strength depends on the novelty and non-obviousness of the claimed compounds. Prior art searches are necessary to evaluate invalidity risks.
3. Are there any licensing opportunities?
Potential licensing deals may arise with the patent owner, especially for commercial applications in CNS therapy markets.
4. What jurisdictions are protected by the global patent family?
Additional filings in Europe (EP patents), Japan (JP patents), and China (CN patents) extend protection internationally.
5. How does this patent influence drug development in its therapeutic area?
It potentially blocks competitors from developing similar compounds within the scope, impacting R&D strategies in neuropsychiatric drug development.
Sources
- U.S. Patent and Trademark Office, Patent 11,077,098.
- LexisNexis Patent Solutions, Patent Landscape Reports.
- European Patent Office, Patent Families Database.
- World Intellectual Property Organization, Patent Cooperation Treaty (PCT) data.
- Industry reports on CNS drug patenting trends.
